This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

    More

    Page   1/2   
  • Measuring the return from pharmaceutical innovation 2013
    For the last four years Deloitte and Thomson Reuters have analysed the performance of the top 12 life sciences companies by estimating the projected financial returns from the investment in their late stage pipelines.
  • Growth and profitability under pressure
    Deloitte´s approach to growth and profitability comprises of key strategic measures designed to counter market challenges and maximise both top- and bottom-line benefits.
  • Impact of European Austerity on Pharmaceutical policy and pricing
    A UK Deloitte Centre for Health solutions report that looks to understand the current European pharmaceutical market, the mechanisms for reducing pharmaceutical spending, the future of the pharmaceutical landscape, and the actions the pharmaceutical industry needs to take to survive current austerity.
  • Measuring the return from pharmaceutical innovation 2012
    For the last three years, Deloitte LLP and Thomson Reuters have analysed the performance of the top 12 life sciences companies by estimating the projected financial returns from the investment in their late stage pipelines.
  • Product Life Cycle Management in Life Sciences Industry
    Evolving from siloed to cross-functional management.
  • The Pricing Survey
    Increasing price pressure and fast eroding margins in the Medical Devices industry.
  • Time to transform your Global Trade Operations
    Improve efficiency, reduce cost and risks in your cross border supply chain
  • Measuring the return from innovation
    Against a backdrop of rising costs and declining output, R&D leaders in the life sciences industry are under continued pressure to justify the investment in R&D.
  • Discovering new business potential
    Integrated Document Management along the Life Sciences industry value chain
  • Product Life Cycle Management in Life Sciences Industry
    Life Sciences companies are currently experiencing a period of unprecedented change.
  • Page   1/2   
Stay connected
Get connected
Share your comments